Health
Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents – Contagionlive.com
The newest data for the real-world assessment show the mRNA vaccine provides greater immunogenicity in persons aged 12-15 years old than in young adults.
Pfizer-BioNTech COVID-19 vaccine BNT162b2 provided an observed vaccine efficacy of 100% among adolescents aged 12-15 years old after 7 days post-administration with the 2-dose product.
The new findings from an ongoing, placebo-controlled, observer-blinded assessment of the mRNA vaccine in adolescent patients suggest BNT162b2 provides an even greater immune response in the population than that observed in vaccinated young adults.
Led by Robert W. Frenck, Jr., MD, of the Cincinnati Childrens Hospital,…
-
Noosa News16 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News22 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Noosa News8 hours agoItalian Film Festival, Brisbane: All the Details
-
Business21 hours agoAre BHP shares are buy after its results?